Curriculum Vitae

My CV as Wordle

This is my professional life boiled down to a wordle. I processed my CV to generate a visual keyword map just to see where my strengths lie relative to my current line of work. Pretty evident – clinical – but what was surprising was the groups of words that were almost as prominent. Definitely an interesting exercise.

Anyway, the best place to get a current snapshot of what I am doing is probably my public LinkedIn profile at http://ca.linkedin.com/in/shawivan. If you are already part of LinkedIn you can access additional details depending on the relationship and whether you bought additional access.

If you do need a formal copy of my CV, please use the contact page to let me know.

Publications List

My citation map isn’t up to date, primarily because Microsoft only lists five articles and unfortunately over 2 different entries to boot. That however, will be fixed in due course. Some publications are available electronically; please contact me if you would like a copy of any that aren’t.

 

Original Reports/Chapters Abstracts and Posters
   
  1. Lieb JG, IT Shaw, PP Toskes. Delivery of enzymes into the duodenum in subjects with severe exocrine pancreatic insufficiency (EPI) from a non–enteric-coated enzyme product administered with omeprazole. Pancreas (submitted 08 November 2011).
  2. Jones M, I Shaw, S Ferrazzi, A Eggleston. 2002. Levofloxacin and macrolides in community-acquired pneumonia: meta-analysis [Original title (Russian): Ежегодно регистрируют примерно 4 млн случаев внебольничной пневмонии.].
    Pulmonology 12(4).
  3. Pallister C, SS Jung, I Shaw, J Nalbantoglu, S Gauthier, NR Cashman. 1997. Lymphocyte content of amyloid precursor protein is increased in Down’s syndrome and aging. Neurobiol Aging 18(1):97-103.
  4. McLaurin J, GC Trudel, IT Shaw, JP Antel, NR Cashman. 1995 A human glial hybrid cell line differentially expressing genes subserving oligodendrocyte and astrocyte phenotype. J Neurobiol 26(2):283-293.
  5. Faure M–P, P Gaudreau, I Shaw, NR Cashman, A Beaudet. 1994. Synthesis of a biologically active fluorescent probe for labeling neurotensin receptors. J Histochem Cytochem 42(6):755-763.
  6. Ledoux S, N Rebai, A Dagenais, IT Shaw, J Nalbantoglu, RP Sékaly, NR Cashman. 1993. Amyloid precursor protein in peripheral mononuclear cells is up-regulated with cell activation. J Immunol 150(12):5566-5575.
  7. Cashman NR, I Shaw, H Durham, S Pasternak, K Hastings. 1993. Hybrid cell lines model the normal and abnormal biology of motor neurons. Norris ALS Festschrift Symposium, (chapter) pp. 325-329.
  8. Shaw KT, IT Shaw, P Ryan, MM Stevenson, PA Kongshavn. 1992. Identification of immunodominant Trypanosoma musculi antigens recognized by monoclonal antibody and curative immunoglobulin G2a antibody. Int J Parasitol 22(5):603-612.
  9. Cashman NR, HD Durham, JK Blusztajn, K Oda, T Tabira, IT Shaw, S Dahrouge, JP Antel. 1992. Neuroblastoma x spinal cord (NSC) hybrid cell lines resemble developing motor neurons. Dev Dyn 194(3):209-221.
  10. Faure M–P, I Shaw, P Gaudreau, N Cashman, A Beaudet. 1992. Binding and internalization of neurotensin in hybrid cells derived from septal cholinergic neurons. Ann NY Acad Sci 668:345-347.
  11. Cashman NR, R Loertscher, J Nalbantoglu, I Shaw, RJ Kascsak, DC Bolton, PE Bendheim. 1990. Cellular isoform of the scrapie agent protein participates in lymphocyte activation. Cell 61(1):185-192.

 

  1. King TA, DC Subich, IT Shaw. 2012. PYLERA™ + omeprazole quadruple therapy for Helicobacter pylori demonstrates high efficacy with minimal risk of bismuth-associated neurotoxic symptoms. XXV International Workshop of the Helicobacter Study Group (Ljubijana, Slovenia; presented 15-Sep-2012).
  2. King TA, DC Subich, IT Shaw, RJ Porter. 2011. Bioavailability of bismuth following 10 day PYLERA™ (bismuth subcitrate potassium,metronidazole, tetracycline hydrochloride) + omeprazole treatment for eradication of Helicobacter pylori. UEGW 2011 Congress (Stockholm; presented 26-Oct-2011).
  3. Konstan, MW, IT Shaw, J Grondin. 2010. Control of steatorrhea with Ultrase MT12® in children 2-6 years of age with cystic fibrosis & pancreatic insufficiency. Pediatr Pulmonol 45(S33):416-417.
  4. Toskes PP, G Rydzewska, JR Basque, V Ratheau, IT Shaw. 2010. Safety and efficacy of immediate-release pancrelipase, VIOKASE®16, with proton pump inhibitor therapy for correction of steatorrhea in patients with chronic pancreatitis with exocrine pancreatic insufficiency. Gastroenterology 138(5, Suppl 1):S-394.
  5. Lieb J, C Curington, R Coston, MJ Dumoulin, IT Shaw, P Toskes. 2009. Delivery of enzymes into the duodenum of subjects with severe pancreatic exocrine insufficiency (EPI) from a non-enteric coated enzyme preparation administered with omeprazole. Pancreas 38(8):1023.
  6. Jones MP, IT Shaw, S Ferrazzi, A Eggleston. 2001. Levofloxacin and newer macrolides in community-acquired pneumonia: A statistical meta-analysis.
    Proceedings, 17th International Conference on Pharmacoepidemiology.
  7. Shaw I, NR Cashman. 1996. Apoptosis in rat embryonic motor neurons is dependent upon reactive oxygen species. Proceedings, International Alliance of ALS/MND Associations 7th International Symposium on ALS/MND.
  8. Pari G, H Lochmüller, H Durham, I Shaw, N Roy, N Cashman, A MacKenzie, B Massie, G Karpati, J Nalbantoglu. 1996. Functional analysis of the neuronal apoptosis inhibitory protein (NAIP) using adenoviral recombinants (AVR)-containing NAIP expression cassette. Neurology 46(Suppl 1):A112.
  9. Cashman NR, M Bachetti, IT Shaw. 1995. 3,3’5-triiodo-DL-thyroxine (T3)-induced mitochondrial proliferation augments generation of reactive oxygen species (ROS) in apoptosis of the motor neuron-like NSC34 cell line. Soc Neurosci Abs 21:1305.
  10. Shaw IT, M Bachetti, NR Cashman. 1995. Serum deprivation-induced apoptosis of the motor neuron-like NSC34 cell line is accompanied by p53 accumulation and cell cycle arrest. Soc Neurosci Abs 21:1304.
  11. Shaw IT, M Bachetti, NR Cashman. 1994. Reactive oxygen species in apoptosis of serum-deprived neuroblastoma × spinal cord motor neuron cell hybrids. Soc Neurosci Abs 20:432.
  12. Pallister C, I Shaw, S Ledoux, S Gauthier, NR Cashman. 1994. Lymphocyte abundance of amyloid precursor protein APP is increased in Down’s Syndrome and aging. Neurology 44 (Suppl. 1):A206.
  13. Shaw IT, NR Cashman. 1993. CNTF blocks apoptosis in serum-deprived neuroblastoma × spinal cord motor neuron cell hybrids. Soc Neurosci Abs 19:416. [platform presentation]
  14. Cashman NR, A Abdollah, IT Shaw, J Nalbantoglu, A Beaudet. 1991. Apoptosis in a motor neuron-like cell line induced by serum deprivation or 5-azacytidine. Soc Neurosci Abs 17:758.
  15. Faure M–P, I Shaw, P Gaudreau, NR Cashman, A Beaudet. 1991. Binding and internalization of neurotensin in hybrid cells derived from septal cholinergic neurons. Proceedings, Second International Conference on Neurotensin:17.
  16. Faure M–P, I Shaw, DN Hammond, NR Cashman, A Beaudet. 1991. Hybrid cells derived from septal cholinergic neurons express neurotensin receptors. Soc Neurosci Abs 17:806.
  17. Trudel GC, I Shaw, JP Antel, NR Cashman. 1991. Expression of oligodendrocyte and O2A progenitor cell characteristics in a human-human neural hybrid cell line. Soc Neurosci Abs 17:19.
  18. Shaw IT, S Boulet, E Wong, NR Cashman. 1990. Unique immunologic determinants of neuroblastoma-spinal cord (NSC) hybrid cells. Neurology 40 (Suppl 1):273. [platform presentation]
  19. Cashman NR, IT Shaw, KEM Hastings, S Pasternak, HD Durham, JP Antel. 1989. Neuroblastoma-spinal cord (NSC) hybrid cells as probes for motor neuron cell biology. Proceedings, Association Française contre les myopathies:41-42.
Follow

Get every new post delivered to your Inbox

Join other followers: